SWK Holdings is a specialty finance company that provides customized financing solutions to life science companies, institutions, and inventors in biotechnology, medical devices, diagnostics, and pharmaceuticals. The company monetizes healthcare-related cash flow streams through royalty purchases, secured debt financings, and synthetic revenue interests in commercialized products. Operating primarily in an underserved niche of sub-$50 million transaction sizes where larger competitors are less active, it generates income from ownership or financing of royalties, interest and fees from secured debt, and equity appreciation, typically funding transactions up to $25 million from working capital and syndicating larger deals to other investors.